Associated Papers
Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemia.
Sommer C et al.
Scientific Reports, 2025
40987801 (PubMed )
Supplement: 41598_2025_20589_MOESM1_ESM.pdf
The longitudinal dynamics and natural history of clonal haematopoiesis.
Fabre MA et al.
Nature, 2022
35650444 (PubMed )
Supplement: 41586_2022_4785_MOESM11_ESM.xlsx › historical_growth
[Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases].
Fu WJ et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 2019
Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
Manso R et al.
Oncotarget, 2018
29662631 (PubMed )
Supplement: oncotarget-09-16124-s002.xls › Supplementary_Table_3
Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.
Ofran Y et al.
British Journal of Haematology, 2013
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Chou WC et al.
Blood, 2011
Select a paper to view details